Design Opportunities at the Intersection of Sexual and Reproductive Health, Cystic Fibrosis, and Technology
This is a well-scoped qualitative CHI paper whose main contribution is conceptual and design-oriented: it shows why SRH support for people with CF cannot be bolted onto existing tools without accounting for the condition’s care ecology. The award recognition fits a careful, intersectional contribution with clear limits.
Axes Lens
Rare contribution shape, typical evidence profile. The point here is not a score. It is to show what kind of claim the paper makes, and whether the evidence pattern is unusual or baseline in this 268 -review set.
Contribution shape
- Knowledge form
- normative knowledge typical · 31/268
- Novelty type
- design space typical · 10/268
- Abstraction level
- practice typical · 85/268
- Generalization target
- user population typical · 75/268
- Validation mode
- qualitative study typical · 63/268
Evidence profile
- Evidence strength
- moderate typical · 105/268
- Claim alignment
- medium typical · 32/268
- Overclaim risk
- medium typical · 210/268
Review Summary
This paper’s strongest value is not in proposing a single system or algorithm, but in making the intersection of sexual and reproductive health and cystic fibrosis legible as a distinct CHI design problem. The abstract already signals the core move: existing technologies address pieces of female SRH or chronic condition management, yet they “often overlook the unique complexities of these intersecting issues.” That is a meaningful departure from a common-sense additive view of design, where one might assume that SRH features can simply be layered onto CF tools. Instead, the paper argues that the relevant unit of analysis is the coupled lived experience of care, symptoms, and reproductive transitions across menstruation, pregnancy, and menopause. The qualitative study of 16 people with CF provides the empirical basis for that framing, and the contribution is best read as a design-space and normative synthesis rather than a technical artifact or causal finding. The evidence is aligned with that claim, but the scope is intentionally bounded: the participants are predominantly UK-based, recruitment is online, and the paper itself notes limits to generalisability. That makes the work strong as an intersectional field argument and as a source of design implications for FemTech, online communities, AI, and clinical technologies, but not as a broadly generalizable evaluation of interventions. In CHI terms, this is a careful, credible honorable-mention style contribution: conceptually sharp, grounded in qualitative evidence, and valuable for expanding what counts as the relevant problem space in health technology design. The paper also avoids the trap of overclaiming a single intervention. Instead, it repeatedly situates apps, peer support, clinical records, and AI as components of a wider ecology of care, which is a mature and defensible stance. Its limitations section is important because it shows the authors understand the partiality of their sample and the influence of online recruitment and researcher proximity. That makes the paper more trustworthy, not less, because the design implications are presented as situated and conditional rather than universal. Overall, the contribution is a strong intersectional synthesis with clear practical relevance and appropriately bounded claims.
What Changed
Canon before
Prior CHI work on FemTech, chronic illness management, and reproductive health typically treats these as separate problem spaces or focuses on one condition at a time.
Departure from common sense
The paper argues that existing FemTech and CF technologies miss the combined realities of SRH and CF, so adding isolated SRH features is not enough; the design problem is the intersection itself, including care coordination, symptom interpretation, and lived experience across settings.
Actual novelty
The paper’s novelty is in deriving design implications from the intersection of sexual/reproductive health and cystic fibrosis, rather than from either domain alone, and in framing that intersection as a distinct space for technology design. It extends prior CF and SRH work by treating the overlap as a coupled care ecology with distinct coordination, interpretation, and support needs, rather than as a simple feature gap that can be solved by adding menstrual, pregnancy, or menopause tracking to existing tools.
Evidence
The paper presents a qualitative study of 16 people with CF across stages of female SRH and uses those accounts to articulate design opportunities for FemTech, online communities, AI, and clinical technologies. The evidence supports an intersection-focused contribution, but it is not a broad evaluative comparison of technologies. The strongest support comes from the introduction, findings, discussion, and limitations, which together show both the scope of the empirical material and the boundedness of the claims.
“ Within this framing, we present a qualitative study of 16 people with CF to understand their experiences living with the condition and the distributed management of care across home and clinics at different stages of female SRH”
actual novelty · Introduction / contribution framing · confidence 0.78
“ Although we are starting to see studies exploring the intersection between CF and SRH, these have not been conducted with a view to identifying potential opportunities for adapting technological support for combined CF and SRH ecologies of care, which include “formal medical institutions and processes, but also various non-medical social worlds and activities” [ 60 ]”
departure from common sense · Introduction · confidence 0.72
“ The Role of AI in Peer Support for Young People: A Study of Preferences for Human- and AI-Generated Responses. In Proceedings of the 2024 CHI Conference on Human Factors in Computing Systems. 1–18. Google Scholar ”
limitation · Limitations · confidence 0.95
“ Within this framing, we present a qualitative study of 16 people with CF to understand their experiences living with the condition and the distributed management of care across home and clinics at different stages of female SRH”
validation scope · Introduction / method framing · confidence 0.90
Limits
Method limits
The evidence comes from a qualitative interview study, so it supports interpretation and design implications rather than causal claims or performance comparisons. The sample is limited to 16 participants and is shaped by recruitment through online CF communities and a charity-mediated route, which may skew toward engaged participants and those already connected to CF networks.
Deployment limits
The implications are most directly relevant to technologies supporting people with CF who experience female SRH stages and to care contexts where CF management and reproductive health intersect. Transfer to other conditions or health systems should be cautious, especially where care pathways, digital infrastructure, or reproductive services differ substantially from the UK NHS context.
Boundary conditions
Findings are bounded by a UK-based participant pool and online recruitment. The paper’s framing is strongest for people with CF navigating menstruation through menopause, especially within care systems similar to the UK NHS context. The authors also note that some participants were from other countries, but the dominant context remains UK CF care and its referral-based reproductive pathways.
Position in field
This sits at the intersection of CHI health, FemTech, and chronic illness design, extending prior work by treating SRH and CF as a coupled design problem rather than separate domains. It contributes a field-level argument that convergent health concerns require shared data structures, cross-specialty coordination, and technologies that support lived experience as well as clinical workflow.